Sipponen P, Kimura K
Department of Pathology, Jorvi Hospital, Espoo, Finland.
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S79-83.
The pathogenetic association of chronic atrophic gastritis and intestinal metaplasia with gastric cancer implies that the trends seen in these disorders over time should be similar. Both should similarly decrease in incidence with time, and a time-related relationship should occur between the incidence of gastric cancer and the rate of development of atrophic gastritis in the stomach of Helicobacter pylori-infected subjects.
We reviewed some recent studies from Finland on the time trends seen in chronic gastritis, atrophic gastritis (and intestinal metaplasia) and gastric cancer over a period of 15 years (1977-1992). In addition, using results from earlier studies from Japan and Finland, we formed hypotheses on how the time-dependent evolution and extension of atrophic gastritis may accord with the occurrence of gastric cancer in the stomach.
Our investigations showed that the incidence of gastric cancer and the prevalence of H. pylori-associated gastritis, atrophic gastritis and intestinal metaplasia have decreased similarly in outpatient series during the last 15 years. Correspondingly, gastric cancer, atrophic gastritis and intestinal metaplasia are cohort phenomena in the population, and the prevalence rate of atrophic gastritis is correlated with the cohort-specific incidence of gastric cancer; both are high in cohorts born near the beginning of the century but are quite low in those born in recent decades. Since antral and angular areas of the stomach are primary sites for gastric cancer tumours, the earlier investigations indicate that the time-dependent progression of gastritis in grade (development of atrophic gastritis and intestinal metaplasia) and extent (spreading of gastritis by pylorocardial extension) is well correlated with the rate and predisposition of gastric cancer tumours in the distal and angular stomach.
We conclude that atrophic gastritis (or intestinal metaplasia) and gastric cancer are very much alike in time trends and in course. This parallelism favours suggestions that H. pylori-associated gastritis with atrophic and metaplastic sequelae (atrophic gastritis) contribute to the pathogenesis of gastric cancer.
慢性萎缩性胃炎和肠化生与胃癌的发病机制关联表明,这些疾病随时间推移呈现的趋势应相似。两者发病率都应随时间下降,且在幽门螺杆菌感染患者的胃中,胃癌发病率与萎缩性胃炎发展速率之间应存在时间相关关系。
我们回顾了芬兰最近一些关于15年期间(1977 - 1992年)慢性胃炎、萎缩性胃炎(及肠化生)和胃癌时间趋势的研究。此外,利用日本和芬兰早期研究结果,我们就萎缩性胃炎随时间的演变和扩展如何与胃内胃癌发生相符形成了假设。
我们的调查显示,在过去15年门诊病例中,胃癌发病率以及幽门螺杆菌相关性胃炎、萎缩性胃炎和肠化生的患病率均类似下降。相应地,胃癌、萎缩性胃炎和肠化生是人群中的队列现象,萎缩性胃炎患病率与特定队列的胃癌发病率相关;在世纪初出生的队列中两者都高,但在近几十年出生的队列中则相当低。由于胃窦和胃角区域是胃癌肿瘤的主要部位,早期研究表明,胃炎在分级(萎缩性胃炎和肠化生的发展)和范围(通过幽门心肌扩展蔓延的胃炎)方面随时间的进展与远端和胃角部胃癌肿瘤的发生率及易感性密切相关。
我们得出结论,萎缩性胃炎(或肠化生)和胃癌在时间趋势和病程上非常相似。这种平行关系支持了以下观点,即伴有萎缩和化生后遗症(萎缩性胃炎)的幽门螺杆菌相关性胃炎促成了胃癌的发病机制。